Skip to content

The effect of mirror therapy on the lower extremities of children with Hemiplegic cerebral palsy

The efficacy of mirror therapy on lower limb motor function in children with Hemiplegic cerebral palsy 5 to 12 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211106052977N1
Enrollment
24
Registered
2022-08-12
Start date
2021-05-10
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral palsy.

Interventions

Intervention 1: Intervention group: This group undergoes rehabilitation treatment 5 days a week for 4 weeks. In each session, 30 minutes of conventional occupational therapy intervention and 15 minute

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 12 Years

Inclusion criteria

Inclusion criteria: The child should be between 5 and 12 years old. The child should be diagnosed with spastic hemiplegia according to a pediatric neurologist. The child must be able to walk independently at least 10 meters. The child's muscle tone should be less than 3 on the MODIFIED ASHWORTH scale. The child must be able to follow verbal instructions. The child should be at levels one and two according to the GMFCS scale in terms of gross motor function.

Exclusion criteria

Exclusion criteria: The child has uncontrolled seizures. The child has a cognitive disability according to medical history. The child has a problem with hemianopia and unilateral neglect. The child has other neurological diseases. The child has had orthopedic surgery on the lower limb according to medical history. The child has a fixed limit on range of motion in the lower limb joints. According to medical history, the child has Auditory acuity problems that have not been corrected or treated. According to medical history, the child has Visual acuity problems that have not been corrected or treated. The child had a Botox injection in the lower limb for up to 6 months before the intervention.

Design outcomes

Primary

MeasureTime frame
Dynamic balance score in the timed up and go test. Timepoint: Determining the dynamic balance score before the intervention, at the end of the intervention period and one month after the intervention. Method of measurement: Timed Up and Go Test.;Static balance score in the pediatric balance scale. Timepoint: Determining the static balance score before the intervention, at the end of the intervention period and one month after the intervention. Method of measurement: pediatric balance scale.;Step length obtained by analyzing data of gait analysis system. Timepoint: Determining the length of the step before the intervention, at the end of the intervention period and one month after the intervention. Method of measurement: gait analysis system.;Stride length obtained by analyzing data of gait analysis system. Timepoint: Determining the length of the stride before the intervention, at the end of the intervention period and one month after the intervention. Method of measurement: gait analysis system.;Stance phase time obtained by analyzing data of gait analysis system. Timepoint: Determining the stance phase time before the intervention, at the end of the intervention period and one month after the intervention. Method of measurement: gait analysis system.;Swing phase time obtained by analyzing data of gait analysis system. Timepoint: Determining the swing phase time before the intervention, at the end of the intervention period and one month after the intervention. Method of measurement: gait analysis system.;Spasticity score calculated using the modified Ashworth scale. Timepoint: Determination of spasticity before the intervention, at the end of the intervention period and one month after the intervention. Method of measurement: modified Ashworth scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReihaneh Askary Kachoosangy

Shahid Beheshti University of Medical Sciences

re-askary@sbmu.ac.ir00982173430

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026